Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 26, Issue 8, Pages 1791-1798
Publisher
Oxford University Press (OUP)
Online
2015-04-24
DOI
10.1093/annonc/mdv191
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PIK3CA Mutations in Advanced Cancers: Characteristics and Outcomes
- (2015) Filip Janku et al. Oncotarget
- Unique molecular signatures as a hallmark of patients with metastatic breast cancer: Implications for current treatment paradigms
- (2015) Jennifer J. Wheler et al. Oncotarget
- A cancer trial scandal and its regulatory backlash
- (2014) Razelle Kurzrock et al. NATURE BIOTECHNOLOGY
- Assessing PIK3CA and PTEN in Early-Phase Trials with PI3K/AKT/mTOR Inhibitors
- (2014) Filip Janku et al. Cell Reports
- L01.01 * NO ABSTRACT AVAILABLE
- (2013) ANNALS OF ONCOLOGY
- Integrated molecular portrait of non-small cell lung cancers
- (2013) Vladimir Lazar et al. BMC Medical Genomics
- Prevalence of Off-Label Use and Spending in 2010 Among Patent-Protected Chemotherapies in a Population-Based Cohort of Medical Oncologists
- (2013) Rena M. Conti et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic Medicine Frontier in Human Solid Tumors: Prospects and Challenges
- (2013) Rodrigo Dienstmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Designing Transformative Clinical Trials in the Cancer Genome Era
- (2013) Stefan Sleijfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Existing and Emerging Technologies for Tumor Genomic Profiling
- (2013) Laura E. MacConaill JOURNAL OF CLINICAL ONCOLOGY
- Emerging landscape of oncogenic signatures across human cancers
- (2013) Giovanni Ciriello et al. NATURE GENETICS
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- Pilot Studies for Personalized Cancer Medicine: Focusing on the Patient for Treatment Selection
- (2013) L. De Mattos-Arruda et al. ONCOLOGIST
- Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative
- (2012) A.-M. Tsimberidou et al. CLINICAL CANCER RESEARCH
- Translating cancer 'omics' to improved outcomes
- (2012) E. A. Vucic et al. GENOME RESEARCH
- PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies HarboringPIK3CAMutations
- (2012) Filip Janku et al. JOURNAL OF CLINICAL ONCOLOGY
- Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
- (2012) Gerald S Falchook et al. LANCET
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Overcoming implementation challenges of personalized cancer therapy
- (2012) Funda Meric-Bernstam et al. Nature Reviews Clinical Oncology
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biology-Driven Phase II Trials: What Is the Optimal Model for Molecular Selection?
- (2011) Fabrice Andre et al. JOURNAL OF CLINICAL ONCOLOGY
- Influence of Race, Insurance, Socioeconomic Status, and Hospital Type on Receipt of Guideline-Concordant Adjuvant Systemic Therapy for Locoregional Breast Cancers
- (2011) Xiao-Cheng Wu et al. JOURNAL OF CLINICAL ONCOLOGY
- WIN Consortium—challenges and advances
- (2011) John Mendelsohn et al. Nature Reviews Clinical Oncology
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
- (2011) S. Roychowdhury et al. Science Translational Medicine
- A Sense of Urgency: Evaluating the Link between Clinical Trial Development Time and the Accrual Performance of Cancer Therapy Evaluation Program (NCI-CTEP) Sponsored Studies
- (2010) S. K. Cheng et al. CLINICAL CANCER RESEARCH
- Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers
- (2010) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
- (2009) AD Barker et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cancer: The Road to Amiens
- (2008) David J. Stewart et al. JOURNAL OF CLINICAL ONCOLOGY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now